Delivery Order SPE2DB22D3016-SPE2DB25FAVS6

Award Date 5/6/25
Potential Completion Date 5/28/25
Potential Value $26K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $42,641.70, is for the supply of VYVGART 400 MG/20 ML VIAL 20ML, a pharmaceutical product. The contract has a period of performance through March 6, 2025 and is a Firm Fixed Price type contract. This contract is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the medication VYVGART 400 MG/20 ML VIAL 20ML. The contract has a firm fixed price of $17,056.68 and a performance period through May 19, 2025. The contract is not set aside and was awarded on April 28, 2025. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of VYVGART 400 MG/20 ML VIAL 20ML, a specialty medication. The contract has a firm fixed-price pricing type and a ceiling value of $8,103.66. It is not set aside for any specific business category. The award date is July 17, 2024, and the ultimate completion date is August 7, 2024. AmerisourceBergen, through its extensive...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $34,113.36, is for the provision of VYVGART 400 MG/20 ML VIAL 20ML, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of February 12, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a Delivery Order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp's Corporate Office Division. The contract is for the supply of VYVGART 400 MG/20 ML VIAL 20ML, a specialty pharmaceutical product, with a ceiling value of $16,207.28. The contract has an ultimate completion date of October 16, 2024 and is a Firm Fixed Price Delivery Order. AmerisourceBergen is a major supplier of pharmaceutical products and medical supplies to the U.S....
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract, with a ceiling value of $25,585.02, is for the delivery of VYVGART 400 MG/20 ML VIAL 20ML, a pharmaceutical product. This is a delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation. The order is for VYVGART 400 MG/20 ML VIAL 20ML, a pharmaceutical product. The contract has a ceiling value of $24,310.92 and a completion date of June 4, 2024. The contract is a firm fixed price delivery order and is not designated as a set-aside. AmerisourceBergen Drug Corporation is a subsidiary of Cencora, Inc., one of the largest pharmaceutical distribution...
This is a firm fixed-price delivery order awarded to AmerisourceBergen Drug Corp by the Defense Logistics Agency (DLA) for the supply of VYVGART 400 MG/20 ML VIAL 20ML, a pharmaceutical product. The contract has a ceiling value of $8,103.66 and an ultimate completion date of October 4, 2024. AmerisourceBergen is a major supplier of pharmaceutical and medical products to the U.S. federal government, including military treatment facilities and veterans' hospitals. This award is part of a larger...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The contract, valued at $16,207.28, is for the delivery of VYVGART 400 MG/20 ML VIAL 20ML, a pharmaceutical product. The contract has a firm fixed price pricing type and a completion date of May 7, 2024. It is not designated as a set-aside contract. In addition...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,528.34 firm fixed-price delivery order is for the supply of VYVGART 400 MG/20 ML VIAL 20ML, a pharmaceutical product, with a completion date of January 23, 2025. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical....
  • SPE2DB22D3016
    Indefinite Delivery Contract
  • SPE2DB22D3016-SPE2DB25FAVS6
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VYVGART 400 MG/20 ML VIAL 20ML, a prescription medication, with a ceiling value of $25,585.02 and a performance period ending on May 28, 2025. The contract is a firm fixed-price, non-set-aside award, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle to supply a vast range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.

Generated 8/10/25, 1:25 AM